25th Apr 2016 08:29
LONDON (Alliance News) - Oxford BioMedica PLC Monday said Chairman Lorenzo Tallarigo bought 41,083 shares at 6.425 pence each on Friday.
Following the purchase, Tallarigo now holds 119,003 shares in the gene and cell therapy group.
The stock was down 0.2% at 6.22p Monday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica